losartan has been researched along with Familial Hypokalemia-Hypomagnesemia in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with Losartan and PD123319 in controls reduced MKP-1 and elevated ERK1/2 phosphorylation to the level observed in BS/GS patients treated with PD123319." | 5.36 | Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension. ( Calò, LA; D'Angelo, A; Davis, PA; Mormino, P; Pagnin, E; Pessina, AC; Schiavo, S, 2010) |
| "Treatment with Losartan and PD123319 in controls reduced MKP-1 and elevated ERK1/2 phosphorylation to the level observed in BS/GS patients treated with PD123319." | 1.36 | Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension. ( Calò, LA; D'Angelo, A; Davis, PA; Mormino, P; Pagnin, E; Pessina, AC; Schiavo, S, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calò, LA | 1 |
| Schiavo, S | 1 |
| Davis, PA | 1 |
| Pagnin, E | 1 |
| Mormino, P | 1 |
| D'Angelo, A | 1 |
| Pessina, AC | 1 |
1 other study available for losartan and Familial Hypokalemia-Hypomagnesemia
| Article | Year |
|---|---|
Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
Topics: Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Block | 2010 |